Tom Anderson

4.7k total citations · 1 hit paper
88 papers, 3.7k citations indexed

About

Tom Anderson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tom Anderson has authored 88 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 23 papers in Surgery. Recurrent topics in Tom Anderson's work include Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Research Studies (10 papers) and Cancer Treatment and Pharmacology (10 papers). Tom Anderson is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Research Studies (10 papers) and Cancer Treatment and Pharmacology (10 papers). Tom Anderson collaborates with scholars based in United States, United Kingdom and Philippines. Tom Anderson's co-authors include Leonard A. Zwelling, Kurt W. Kohn, Robert C. Young, Richard M. Hansen, Vincent T. DeVita, Paul S. Ritch, Philip S. Schein, Mary G. McMenamin, Richard I. Fisher and Richard Simon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Tom Anderson

87 papers receiving 3.4k citations

Hit Papers

DNA-protein and DNA interstrand cross-linking by cis- and... 1979 2026 1994 2010 1979 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Anderson United States 32 1.6k 820 798 745 730 88 3.7k
Nissim Haim Israel 37 1.2k 0.7× 1.1k 1.3× 1.3k 1.6× 453 0.6× 598 0.8× 155 3.8k
F. Cavalli Switzerland 33 2.2k 1.3× 660 0.8× 1.5k 1.8× 511 0.7× 705 1.0× 147 4.0k
G. Blackledge United Kingdom 34 1.2k 0.7× 1.3k 1.6× 914 1.1× 853 1.1× 517 0.7× 125 3.8k
James L. Speyer United States 37 2.2k 1.4× 788 1.0× 473 0.6× 1.0k 1.4× 928 1.3× 94 4.4k
Jeffrey A. Gottlieb United States 32 2.6k 1.6× 1.2k 1.5× 1.0k 1.3× 499 0.7× 946 1.3× 73 5.2k
L B Grochow United States 32 2.2k 1.3× 523 0.6× 276 0.3× 344 0.5× 1.8k 2.5× 48 3.6k
Lindsey Gumbrell United Kingdom 17 1.3k 0.8× 564 0.7× 549 0.7× 392 0.5× 932 1.3× 24 2.7k
Ralph Levitt United States 27 2.1k 1.3× 892 1.1× 407 0.5× 682 0.9× 670 0.9× 67 3.6k
Geoffrey Falkson South Africa 43 3.4k 2.1× 2.0k 2.4× 1.1k 1.4× 1.2k 1.6× 915 1.3× 264 6.8k
Elaine M. Rankin United Kingdom 28 2.1k 1.3× 1.5k 1.9× 357 0.4× 350 0.5× 731 1.0× 60 3.5k

Countries citing papers authored by Tom Anderson

Since Specialization
Citations

This map shows the geographic impact of Tom Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Anderson more than expected).

Fields of papers citing papers by Tom Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Anderson. The network helps show where Tom Anderson may publish in the future.

Co-authorship network of co-authors of Tom Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Anderson. A scholar is included among the top collaborators of Tom Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Anderson. Tom Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krasnow, Arthur Z., Robert S. Hellman, M E Timins, et al.. (1997). Diagnostic bone scanning in oncology. Seminars in Nuclear Medicine. 27(2). 107–141. 67 indexed citations
2.
Siegelman, Evan S., Eric K. Outwater, M P Banner, et al.. (1997). High-resolution MR imaging of the vagina.. Radiographics. 17(5). 1183–1203. 66 indexed citations
3.
Hansen, Richard M., Louise Ryan, Tom Anderson, et al.. (1996). Phase III Study of Bolus Versus Infusion Fluorouracil With or Without Cisplatin in Advanced Colorectal Cancer. JNCI Journal of the National Cancer Institute. 88(10). 668–674. 102 indexed citations
4.
Hansen, Richard M., Peter A. Beatty, Edward J. Quebbeman, & Tom Anderson. (1993). A Phase I Trial of Protracted 5-Fluorouracil Infusion and Oral Calcium Leucovorin. Cancer Investigation. 11(3). 247–251. 5 indexed citations
5.
Komorowski, Richard, et al.. (1992). Immature teratoma of the ovary—An unusual case. Gynecologic Oncology. 46(1). 111–114. 15 indexed citations
6.
Erickson, Bradley A., Gerald J. Harris, Kevin Murray, et al.. (1992). Periocular lymphoproliferative diseases: natural history, prognostic factors, and treatment.. Radiology. 185(1). 63–70. 8 indexed citations
7.
Hansen, Richard M., Paul S. Ritch, Joseph A. Libnoch, & Tom Anderson. (1991). Continuous 5-Fluorouracil Infusion and Alpha Interferon in Advanced Cancers: A Report of Initial Treatment Results. The American Journal of the Medical Sciences. 301(4). 246–249. 7 indexed citations
8.
Hansen, Richard M., Timothy J. Moynihan, Edward J. Quebbeman, et al.. (1991). Continuous systemic 5-fluorouracil infusion in refractory prostatic cancer. Urology. 37(4). 358–361. 24 indexed citations
9.
Chitambar, Christopher R., et al.. (1991). Evaluation of continuous infusion low‐dose 5‐azacytidine in the treatment of myelodysplastic syndromes. American Journal of Hematology. 37(2). 100–104. 40 indexed citations
10.
Neidhart, James A., W Köhler, Christine A. Stidley, et al.. (1990). Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation.. Journal of Clinical Oncology. 8(10). 1728–1738. 40 indexed citations
11.
Janjan, Nora A., Tom Anderson, Robert D. Siegel, & Donald A. Hackbarth. (1990). Angiosarcoma of the Forearm Definitively Treated by Hyperfractionated Irradiation. American Journal of Clinical Oncology. 13(6). 489–494. 9 indexed citations
12.
Ash, Robert C., James T. Casper, Christopher R. Chitambar, et al.. (1990). Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated Donors. New England Journal of Medicine. 322(8). 485–494. 211 indexed citations
13.
Hansen, Richard M., et al.. (1990). 5-Fluorouracil Infusion and Low-Dose Weekly Cisplatin. American Journal of Clinical Oncology. 13(6). 485–488. 4 indexed citations
14.
Hansen, Richard M., Edward J. Quebbeman, & Tom Anderson. (1989). 5-Fluorouracil by Protracted Venous Infusion. Oncology. 46(4). 245–250. 28 indexed citations
15.
Sadeghi, Ezedin M., et al.. (1988). Embryonal rhabdomyosarcoma. International Journal of Oral and Maxillofacial Surgery. 17(3). 198–200. 7 indexed citations
16.
Janjan, Nora A., J. Frank Wilson, Michael T. Gillin, et al.. (1988). Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer. 61(2). 252–254. 31 indexed citations
17.
Hansen, Richard M., Edward J. Quebbeman, Paul S. Ritch, et al.. (1987). Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Research and Treatment. 10(2). 145–149. 64 indexed citations
18.
Hansen, Richard M., James G. Caya, Lawrence J. Clowry, & Tom Anderson. (1984). Benign mesothelial proliferation with effusion. The American Journal of Medicine. 77(5). 887–892. 14 indexed citations
19.
Young, Robert C., Tom Anderson, & Vincent T. DeVita. (1977). The treatment of Hodgkin's disease. Current Problems in Cancer. 1(7). 1–29. 11 indexed citations
20.
Ps, Schein, et al.. (1976). Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.. PubMed. 60(6). 801–5. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026